Email

william.brasher@bcm.edu

Positions

Assistant Professor

Medicine - Pulmonary
Baylor College of Medicine

Education

Clinical Fellowship at University of Texas Health Science Center at Houston

06/2022 - Houston, Texas United States

Residency at Baylor College of Medicine

06/2018 - Houston, Texas United States

MD from Virginia Commonwealth University School of Medicine

06/2015 - Richmond, Virginia United States

BS from The University of Virginia

06/2009 - Charlottesville, Virginia United States

Certifications

Pulmonary Medicine

American Board of Internal Medicine

Critical Care Medicine

American Board of Internal Medicine

Internal Medicine

American Board of Internal Medicine

Honors & Awards

Best Supporting Fellow

Baylor College of Medicine (01/2020 - 12/2020)

Chief Pulmonary and Critical Care Fellow

Baylor College of Medicine (01/2021 - 12/2021)

Professional Interests

• Pulmonary Vascular Disease
• Pulmonary Embolism
• Pulmonary Hypertension
• Chest Infections
• Pulmonary Complications of Malignancy

Professional Statement

I am currently an assistant professor of pulmonary and critical care medicine at Baylor College of Medicine working primarily at Ben Tub Hospital. In my current role, I have started a pulmonary hypertension clinic and am the director of the pulmonary hypertension program and co-director of the Pulmonary Embolism Response Team (PERT) at Ben Taub. In addition to pulmonary vascular disease. I have interests in pulmonary infections, malignancy, global health, and medical education.

Selected Publications

• Banala C, Brasher WP, Kanagal Shamanna R, Bashoura, L, Faiz SA. "Consolidative opacity in a patient with acute leukemia.." Clin Case Rep.. 2022;
• Panchagnula, N., Brasher, W. P. "Hyperglycemia and Venous Thromboembolism." Diagnostics (Basel). 2024;
• Soto, F., Ebinama, U., Brasher, WP, Harding, W. C., Goizueta, A., Walder, J. R., Ewing, A., Shannon, V. R., Faiz, S. A., Altan, M., Shroff, G., Feng, L., Neelapu, S., Ahmed, S., Nastoupil, L. J., & Sheshadri, A. "Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory Lymphoma.." Clinical Lymphoma, Myeloma and Leukemia. 2025;
• Brasher WP, Bvumbwe M, Kazembe PN. "Infection or Drug Toxicity? Acute ataxia and encephalopathy after Uncomplicated falciparum malaria and efavirenz dose adjustment.." Malawi Med J.. 2020;